BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+3.33%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$7.83B
AUM Growth
+$7.83B
Cap. Flow
+$156M
Cap. Flow %
2%
Top 10 Hldgs %
76.26%
Holding
100
New
11
Increased
18
Reduced
12
Closed
5

Top Buys

1
INSM icon
Insmed
INSM
$217M
2
SMMT icon
Summit Therapeutics
SMMT
$181M
3
ALKS icon
Alkermes
ALKS
$101M
4
BCYC
Bicycle Therapeutics
BCYC
$90.2M
5
ALMS
Alumis Inc. Common Stock
ALMS
$20.8M

Top Sells

1
INCY icon
Incyte
INCY
$330M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
$62.1M
3
ROIV icon
Roivant Sciences
ROIV
$48.8M
4
AKRO icon
Akero Therapeutics
AKRO
$37.9M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$37.5M

Sector Composition

1 Healthcare 98.13%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ADAP
76
Adaptimmune Therapeutics
ADAP
$13.9M
$2.28M 0.03%
2,343,695
-8,443,327
-78% -$8.23M
MRSN icon
77
Mersana Therapeutics
MRSN
$34.8M
$2.18M 0.03%
1,086,115
– –
IPSC icon
78
Century Therapeutics
IPSC
$40.4M
$2.03M 0.03%
797,460
– –
NAMS icon
79
NewAmsterdam Pharma
NAMS
$2.8B
$1.86M 0.02%
96,827
– –
SAGE
80
DELISTED
Sage Therapeutics
SAGE
$1.86M 0.02%
171,026
-236,191
-58% -$2.57M
VTVT icon
81
vTv Therapeutics
VTVT
$49.4M
$1.72M 0.02%
97,314
– –
CMPX icon
82
Compass Therapeutics
CMPX
$466M
$1.56M 0.02%
1,557,630
– –
TARA icon
83
Protara Therapeutics
TARA
$125M
$1.12M 0.01%
536,832
+337,161
+169% +$701K
JBIO
84
Jade Biosciences, Inc. Common Stock
JBIO
$245M
$1.04M 0.01%
628,939
-1,051,578
-63% -$1.75M
PFE icon
85
Pfizer
PFE
$141B
$979K 0.01%
35,000
– –
ACHL
86
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
$904K 0.01%
1,108,767
-100,008
-8% -$81.5K
ALGS icon
87
Aligos Therapeutics
ALGS
$75.1M
$727K 0.01%
2,076,400
– –
PMVP icon
88
PMV Pharmaceuticals
PMVP
$82.1M
$522K 0.01%
322,024
– –
BCRX icon
89
BioCryst Pharmaceuticals
BCRX
$1.74B
$468K 0.01%
75,778
-10,050,398
-99% -$62.1M
ACRV icon
90
Acrivon Therapeutics
ACRV
$42.2M
$307K ﹤0.01%
52,885
– –
FHTX icon
91
Foghorn Therapeutics
FHTX
$298M
$259K ﹤0.01%
45,027
– –
TYRA icon
92
Tyra Biosciences
TYRA
$657M
$170K ﹤0.01%
10,607
– –
SRZNW icon
93
Surrozen, Inc. Warrant
SRZNW
$71.9K
$13.8K ﹤0.01%
833,333
– –
ALPN
94
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
– –
-81,578
Closed -$3.23M
MURA icon
95
Mural Oncology
MURA
$35.9M
– –
-222,503
Closed -$1.09M
FDMT icon
96
4D Molecular Therapeutics
FDMT
$302M
– –
-100,000
Closed -$3.19M
CATX icon
97
Perspective Therapeutics
CATX
$251M
– –
-149,787
Closed -$178K
CABA icon
98
Cabaletta Bio
CABA
$144M
– –
-13,331
Closed -$227K
1 2 3
4